Invivyd (IVVD) Other Operating Expenses (2021 - 2025)
Invivyd (IVVD) posted Other Operating Expenses of $1.1 million for Q4 2025, up 4.78% on a QoQ basis from $1.1 million in Q3 2025, and up 57.46% year-over-year from $724000.0 in Q4 2024.
Invivyd (IVVD) Other Operating Expenses (2021 - 2025) Analysis & Trends
Invivyd's Other Operating Expenses history runs 5 years deep, the most recent figure standing at $1.1 million for Q4 2025.
- Quarterly Other Operating Expenses rose 57.46% year-over-year to $1.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.7 million (up 131.58% YoY) and the FY2025 annual result came in at $3.7 million, up 131.58% from the prior year.
- Other Operating Expenses was $1.1 million for Q4 2025 at Invivyd, up from $1.1 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $17.8 million in Q4 2022 and bottomed at -$600000.0 in Q4 2023.
- A 5-year average of $2.5 million and a median of $917000.0 in 2021 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2023 — Other Operating Expenses slumped 103.38% — and 2025, when it surged 678.41%.
- Invivyd's Other Operating Expenses stood at $4.0 million in 2021, then jumped by 344.32% to $17.8 million in 2022, then slumped by 103.38% to -$600000.0 in 2023, then jumped by 220.67% to $724000.0 in 2024, then soared by 57.46% to $1.1 million in 2025.
- Business Quant data shows IVVD's Other Operating Expenses at $1.1 million in Q4 2025, $1.1 million in Q3 2025, and $685000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Invivyd | 104.07 Mn | -122.62 Mn | 16.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.14 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Jun 30, 2025 | 685,000.00 |
| Mar 31, 2025 | 834,000.00 |
| Dec 31, 2024 | 724,000.00 |
| Sep 30, 2024 | 806,000.00 |
| Jun 30, 2024 | 88,000.00 |
| Dec 31, 2023 | -600,000.00 |
| Sep 30, 2023 | 4.60 Mn |
| Jun 30, 2023 | 150,000.00 |
| Mar 31, 2023 | 825,000.00 |
| Dec 31, 2022 | 17.77 Mn |
| Sep 30, 2022 | 4.00 Mn |
| Sep 30, 2021 | 4.00 Mn |
| Jun 30, 2021 | 2.50 Mn |
| Mar 31, 2021 | 1.00 Mn |